Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon Aug 23, 2022 2:35pm
99 Views
Post# 34914940

RE:RE:RE:RE:AUG 24 AGM cancelled

RE:RE:RE:RE:AUG 24 AGM cancelledYes the insiders have the majority of the stock and you can bet that the major shareholders know what is going on.  It is just us "peasants" that are being kept in the dark.  Surely they have a planned timeline of how much more testing and tweeking is needed on the dermal injector before submitting it for FDA Approval.  For cr_p sake why can they not share it with us. ?  Also now that we are less than 60 days from the deadline for the Arbitration ruling they must have been told when a decision will be rendered.  Can we at lest have that.  I can understand that they need to keep the inner details of how the Arbitration has gone in confidence.

The only saving grace for me at the moment is those large shareholders that are in the know are not selling at this point.  If over the next number of weeks their is some big volume sold it will be time to head for the exits because if all goes bad your stocks will be worthless.
<< Previous
Bullboard Posts
Next >>